MDY Mdy Healthcare

RNS Number:5413O
MDY Healthcare PLC
22 December 2006









          MDY Healthcare plc leads private placing for Medivance, Inc.





22nd December 2006 - MDY Healthcare plc, the strategic investor in healthcare
companies, today announces that it has subscribed for $2,500,000 in convertible
loan notes in Medivance, Inc in a private placing arranged by Piper Jaffray with
MDY Healthcare acting as lead investor.



Based in Boulder, Colorado, Medivance is a leading company in the emerging field
of therapeutic temperature management. The company's non-invasive technology,
Arctic Sun(R) is patented and FDA approved to rapidly cool patients ("
therapeutic hypothermia") and precisely control their temperatures as a
therapeutic tool.  Therapeutic cooling has been shown to reduce brain damage
after traumatic events such as cardiac arrest and brain injury. It also has
potential applications in the treatment of stroke and fever.  Introduced in
2004, the Arctic Sun(R) has been adopted by prestigious hospitals throughout the
US, Europe and Asia.



The private placing has raised a total of $4,540,000 to fund the continued
marketing of the Arctic Sun(R) system around the world.



Commenting on the investment, Charles Spicer, CEO, said:



"We are delighted to be able to invest in Medivance which has a marketed
first-in-class product targeting a fast-growing clinical area backed by an
excellent management team.  As such it meets the criteria we have developed for
our strategic investments in the sector."




For further information, please contact:

MDY Healthcare plc
Charles Spicer, CEO
+44 (0) 207 647 1800
charles.spicer@MDYhealthcare.com

Financial Dynamics
Ben Atwell
+44 (0) 207 831 3113
ben.atwell@fd.com




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

IOEEANAAAEDKFEE

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024